Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Cleveland Clinic Taussig Cancer Center
Ca Building 10201 Carnegie Avenue
Cleveland, OH 44106Phone+1 412-719-9164
Summary
- Dr. Louis Williams is a hematologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Albany Medical College, completed internal medicine training at the Cleveland Clinic, and his fellowship in hematology and medical oncology at the New York University Grossman School of Medicine. He holds an MBA from Yale University School of Management. He has been in practice for 4 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematopoietic stem cell transplantation, cellular therapy, multiple myeloma, and scleromyxedema. He has more than 30 publications and over 150 citations.
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2018 - 2021
- Cleveland Clinic FoundationResidency, Internal Medicine, 2015 - 2018
- Albany Medical CollegeClass of 2015
Certifications & Licensure
- OH State Medical License 2015 - 2025
- NY State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma.Daniel Cancilla, Daniel Paul Nurse, Wei Wei, Danielle Cenin, Christina Ferraro
Annals of Hematology. 2024-12-01 - Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma.Olga Lytvynova, Jenna Jwayyed, Daniel Pastel, Rohan Prasad, Jack Khouri
Antibodies. 2024-09-29 - 3 citationsOutcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.Danai Dima, Michael Hughes, Mark Orland, Fauzia Ullah, Utkarsh Goel
Amyloid. 2024-09-01
Journal Articles
- Deep sequencing as an approach to understanding the complexity and improving the treatment of multiple myelomaLouis Williams, Jessica Caro, Beatrice Razzo, Eileen Boyle & Gareth J. Morgan, Expert Review of Precision Medicine and Drug Development, 7/7/2020
Press Mentions
- ASH 2018: Dec 1-4December 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: